At the experimental level, Tan et al. [115] demonstrated that inhibition of gal-3 expression in a rat model of atherosclerosis resulted in an improved lipid profile (decrease in TG, LDL-C, TC, and elevation in HDL-C), suggesting a potential role of gal-3 in cholesterol metabolism. The gene discussed is LGALS3; the disease is atherosclerosis.